Adebrelimab Maintenance Therapy for LS-SCLC Post Induction Chemo-Adebrelimab Plus CRT or CRT Alone
Clinical trial NCT07381543 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07381543
- Sponsor
- Peking University Cancer Hospital & Institute
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-01
- Primary completion
- 2028-08-01
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.